Clinical Study

Effect of Curcuma xanthorrhiza Supplementation on Systemic Lupus Erythematosus Patients with Hypovitamin D Which Were Given Vitamin D3 towards Disease Activity (SLEDAI), IL-6, and TGF-β1 Serum

Table 3

Effects of C. xanthorrhiza supplementation on vitamin D3 administration towards cytokine levels.

VariableVitamin D3 + placebo ()Vitamin D3 + Curcuma xanthorrhiza ()
PrePost valuePrePost value

IL-6 (pg/ml)12.73.60.0016.85.20.0130.061
(IQR: 6.6–18,1)(IQR: 2.6–4.8)(IQR: 4.7–15.4)(IQR: 3.2–6.4)
TGF-β1 (pg/ml)289.9355.90.000279.3348.40.0110.261
(IQR: 248.8–341.9)(IQR: 328.8–427.1)(IQR: 249.4–313.1)(IQR: 292.1–4386.8)
TGF-β1/IL-6 (pg/ml)35.2 ± 22.378.6 ± 48.70.00330.5 ± 18.1115.6 ± 58.00.0000.038

= differential test of the effects of Curcuma xanthorrhiza supplementation after treatment in both groups, expressed by . There is a significant difference (); IQR: interquartile.